HUM vs MIRM · P/E 39, rev $117.76B vs rev $336.9M
Humana Inc (HUM) versus Mirum Pharmaceuticals Inc (MIRM) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported MIRM revenue for 2024-12-31 was $336.9M. Net income was -$87.9M. Revenue was up 80.8% from 2023-12-31 to 2024-12-31. MIRM currently screens at market cap $6.22B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. MIRM currently screens at market cap $6.22B.
Not investment advice. Open the HUM and MIRM stock pages for the full models.
Not investment advice.